Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

Recent Advances in Cancer Prevention, Risk Factors and Early Diagnosis

Recent Advances in Cancer Prevention, Risk Factors and Early Diagnosis

In 2016, increased awareness of cancer biology changed perspectives on inherited susceptibility mutations. Knowing whether someone carries such mutations became more important because screening and preventive surgeries allow early diagnosis or action before cancer develops. Identifying susceptibility also directly informs family planning and treatment.

Last year, researchers found vitamin B effective in reducing nonmelanoma skin cancer risk. ASCO also published recommendations to increase HPV vaccination, emphasizing its potential to save millions by preventing HPV-related cancers, especially cervical cancer.

New Genes Increasing Ovarian Cancer Susceptibility

Approximately % 10-15 of ovarian cancers are inherited through mutations passed between generations. In women with BRCA1 mutations, ovarian cancer risk is %36, while with BRCA2 it is %12. In the general female population, lifetime risk is %1-2.

A comprehensive recent study identified 2 more susceptibility genes: RAD51C and RAD51D. Women with mutations in these genes have risks respectively 5 and 12 times higher. RAD51 mutations reportedly account for one in every 120 ovarian cancers.

Although relatively rare, knowing these factors enables preventive action. Findings changed national testing guidelines, which now recommend removal of ovaries and tubes to reduce risk in women with RAD51C or RAD51D mutations. Detection also matters after diagnosis because studies suggest these women may respond well to PARP inhibitors , a new drug class.

New Genes Increasing Pancreatic Cancer Susceptibility

About one in every 10 pancreatic cancers involves inherited mutations. Disease in two or more first-degree relatives is called familial pancreatic cancer. Susceptibility involves genes including BRCA1 and BRCA2. A 2015 study found BRCA mutations in % 5 of patients. Another study of 33 Ashkenazi Jewish patients found %12. Despite its small size, this finding changed national guidelines to recommend BRCA1 and BRCA2 testing for every Jewish patient with pancreatic cancer. Appropriate preventive strategies, including screening, can also be recommended to first-degree relatives of identified familial BRCA1 and BRCA2 carriers.

Because a person’s lifetime pancreatic cancer risk is only %1, population-wide pancreatic cancer screening is not recommended. However, for pancreatic cancer, screening high-risk people may detect early disease curable with surgery. A recent study screened asymptomatic people with familial pancreatic cancer or susceptibility-gene mutations (CDKN2A, BRCA1/2, PALB2), totaling 411, using imaging. Among 178 CDKN2A carriers, 13 (% 7) had cancer; 9 underwent surgery and 5-year survival was 5 times higher than in pancreatic cancer generally, at %24. Screening also detected cancer in only two of 214 familial cases (% 0.9) and one of 19 BRCA carriers (% 5). This was the first study showing high-risk screening’s early-detection success and surgical outcomes at that stage. Screening clearly helps CDKN2A carriers; more research is needed in other high-risk groups, including familial disease and BRCA carriers.

Broad Testing to Identify Cancer-Predisposition Mutations

Lynch syndrome markedly increases colorectal, uterine, ovarian, gastric, pancreatic, urinary and other cancers. The syndrome causes mutations in MLH1, MSH2, MSH6, PMS2 and EPCAM. Standard testing screens only these 5 genes, yet approximately half of suspected cases test negative. Other undetected genetic changes may increase risk. To clarify this, researchers developed a technology rapidly analyzing many predisposition genes: multigene panel testing . In 1260 people suitable for standard Lynch testing, 25 susceptibility genes were assessed. In 114 (% 9), mutations involved standard Lynch genes; in 71 (% 6), other predisposition genes. For example, 15 had BRCA1 or BRCA2 mutations associated with breast, ovarian and other cancers, and 9 had a colorectal susceptibility mutation. Panels may detect changes missed by classic Lynch testing, but can also identify uncertain variants causing unnecessary anxiety: %38 had such uncertain findings.

Inherited Mutations in Childhood Cancers

Childhood cancer causes remain poorly understood, including how common inherited susceptibility mutations arise. Better understanding the genetic basis is crucial for treatment and genetic counseling.

Researchers performed a large genomic study of children diagnosed before age 20. Of the genes, 60 were linked to predisposition syndromes, within a total of 565 examined.

Among 1,120 children with cancer, % 8,5 had mutations thought to increase risk, much higher than a control group of 1000 without cancer (% 1.1). Most children with inherited susceptibility mutations (% 60) had no family cancer history.

These findings support more inherited-susceptibility screening in children even without family history. Identifying mutations may influence treatment and family planning. Relatives may then seek their own testing and / or consider preventive measures.

Daily Vitamin B3 May Reduce Skin Cancer Risk

Excess sun exposure is the main skin cancer risk factor. Despite sun-protection campaigns, rates continue rising worldwide. Skin cancers divide into melanoma and nonmelanoma. Melanoma accounts for about %5 but is aggressive; nonmelanoma cancers are common and usually favorable. Skin cancer is the most common cancer in fair-skinned populations. More than one in two Australians will develop nonmelanoma disease; actor Hugh Jackman’s recurrent nasal skin cancer prompted participation in awareness campaigns. In the United States, 5 million receive skin cancer treatment annually. Although rarely fatal, nonmelanoma treatment burdens healthcare.

Over the last decade, researchers examined many vitamins and supplements for prevention. Only a few substances have shown protective properties ( chemoprevention) have been identified. One is nicotinamide, which may reduce the likelihood of skin cancer in high-risk people, a form of vitamin B3.

Vaccinate Both Girls and Boys to Prevent Cervical and Head-and-Neck Cancers

Worldwide research shows HPV vaccination prevents many associated cancers, particularly cervical and head-and-neck cancers. Studies associate %5 of all cancers with HPV, a family of over 100 related viruses. Some cause papillomas, commonly called warts, giving the family its name. Certain types cause cervical, vaginal, anal, vulvar or penile cancers. HPV also appears to increase some head-and-neck cancers, including lower pharyngeal, tonsillar and laryngeal cancers. Though a rare head-and-neck risk factor in our society, HPV-related rates are increasing in Western populations. Recent studies suggest it may become the most important cause. Continuing research confirms public-health benefits of HPV vaccines for preventing cervical and head-and-neck cancers.

Sources

Harold J. Burstein, Lada Krilov, Jeanny B. Aragon-Ching et. al.,
Clinical Cancer Advances 2017: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.
J Clin Oncol 35. 2017 by American Society of Clinical Oncology

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

Recent Advances in Cancer Prevention, Risk Factors and Early Diagnosis

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy